| Bioactivity | 5-(Furan-2-yl)-2’-O-methyl-5’-O-DMTr-cytidine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. |
| Name | 5-(Furan-2-yl)-2’-O-methyl-5’-O-DMTr-cytidine |
| CAS | 2095417-02-8 |
| Formula | C35H35N3O8 |
| Molar Mass | 625.67 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88. |
5-(Furan-2-yl)-2’-O-methyl-5’-O-DMTr-cytidine
CAS: 2095417-02-8 F: C35H35N3O8 W: 625.67
5-(Furan-2-yl)-2’-O-methyl-5’-O-DMTr-cytidine is a purine nucleoside analog. Purine nucleoside analogs have broad anti
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.